Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea
· Delayed Price · Currency is KRW
8,050.00
-300.00 (-3.59%)
Apr 2, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 185,095 | 239,819 | 516,197 | 519,865 | 660,678 | 2,517,196 | |
| Market Cap Growth | -53.54% | -53.54% | -0.71% | -21.31% | -73.75% | - | |
| Enterprise Value | 151,309 | 192,973 | 504,030 | 497,951 | 646,323 | 2,482,604 | |
| Last Close Price | 8050.00 | 10430.00 | 22450.00 | 26694.20 | 33924.69 | 130774.23 | |
| PS Ratio | 97.27 | 126.29 | 37614.61 | - | - | - | |
| PB Ratio | 2.56 | 3.33 | 6.18 | 22.29 | 21.96 | 72.61 | |
| P/TBV Ratio | 3.57 | 3.57 | 6.20 | 22.51 | 22.07 | 72.75 | |
| EV/Sales Ratio | 79.68 | 101.62 | 36727.98 | - | - | - | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Asset Turnover | 0.02 | 0.02 | 0 | - | - | - | |
| Inventory Turnover | 9.19 | 9.19 | - | - | - | - | |
| Quick Ratio | 13.45 | 13.45 | 54.78 | 67.10 | 70.51 | 31.98 | |
| Current Ratio | 13.87 | 13.87 | 55.43 | 68.06 | 71.88 | 32.29 | |
| Return on Equity (ROE) | -13.66% | -13.66% | -19.24% | -25.56% | -14.71% | -18.22% | |
| Return on Assets (ROA) | -11.64% | -11.64% | -13.18% | -18.52% | -11.05% | -11.68% | |
| Return on Capital (ROIC) | -11.92% | -11.92% | -13.41% | -19.11% | -11.30% | -11.94% | |
| Earnings Yield | -5.74% | -4.43% | -1.99% | -1.31% | -0.72% | -0.16% | |
| FCF Yield | -6.93% | -5.35% | -1.86% | -1.20% | -1.03% | -0.13% | |
| Buyback Yield / Dilution | -17.03% | -17.03% | -28.80% | -0.68% | -122.02% | -55.35% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.